Published on 31 May 2023 on Zacks via Yahoo Finance
The Chemours Company CC is benefiting from continued adoption of its Opteon refrigerants, strong execution, higher pricing and cost-cutting measures. However, slow demand recovery may impact its performance.The company’s shares are down 36.3% over a year, compared with 11% decline recorded by its industry.
Zacks Investment Research